PharmaResearch Co., Ltd. 214450.KQ Stock
PharmaResearch Co., Ltd. Price Chart
PharmaResearch Co., Ltd. 214450.KQ Financial and Trading Overview
PharmaResearch Co., Ltd. stock price | 125100 KRW |
Previous Close | 137100 KRW |
Open | 136900 KRW |
Bid | 136900 KRW x 0 |
Ask | 138200 KRW x 0 |
Day's Range | 135800 - 140600 KRW |
52 Week Range | 55000 - 140600 KRW |
Volume | 82.21K KRW |
Avg. Volume | 156.43K KRW |
Market Cap | 1.31T KRW |
Beta (5Y Monthly) | 0.633252 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 124200 KRW |
214450.KQ Valuation Measures
Enterprise Value | 658.46B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 7.141334 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 3.594 |
Enterprise Value/EBITDA | 9.128 |
Trading Information
PharmaResearch Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.633252 |
52-Week Change | 89.88% |
S&P500 52-Week Change | 20.43% |
52 Week High | 140600 KRW |
52 Week Low | 55000 KRW |
50-Day Moving Average | 106822 KRW |
200-Day Moving Average | 77337 KRW |
214450.KQ Share Statistics
Avg. Volume (3 month) | 156.43K KRW |
Avg. Daily Volume (10-Days) | 152.31K KRW |
Shares Outstanding | 9.47M |
Float | 5.94M |
Short Ratio | N/A |
% Held by Insiders | 39.90% |
% Held by Institutions | 15.47% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 25.38% |
Operating Margin (ttm) | 33.72% |
Gross Margin | 71.50% |
EBITDA Margin | 39.37% |
Management Effectiveness
Return on Assets (ttm) | 9.40% |
Return on Equity (ttm) | 13.72% |
Income Statement
Revenue (ttm) | 183.19B KRW |
Revenue Per Share (ttm) | 18362.86 KRW |
Quarterly Revenue Growth (yoy) | 19.30% |
Gross Profit (ttm) | 108.33B KRW |
EBITDA | 72.14B KRW |
Net Income Avi to Common (ttm) | 46.5B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | 31.10% |
Balance Sheet
Total Cash (mrq) | 176.02B KRW |
Total Cash Per Share (mrq) | 17644.85 KRW |
Total Debt (mrq) | 66B KRW |
Total Debt/Equity (mrq) | 18.37 KRW |
Current Ratio (mrq) | 4.603 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 65.74B KRW |
Levered Free Cash Flow (ttm) | 25.77B KRW |
Profile of PharmaResearch Co., Ltd.
Country | South Korea |
State | N/A |
City | Seongnam-si |
Address | 62, Pangyo-ro 255beon-gil |
ZIP | N/A |
Phone | 82 31 8039 1596 |
Website | https://www.pharmaresearch.co.kr |
Industry | |
Sector(s) | |
Full Time Employees | 282 |
PharmaResearch Co., Ltd. operates as a biopharmaceutical company in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; Rejuvenex injection, a tissue regeneration activator that regenerates connective tissues, including ligament, tendon, skin, etc.; Rejuvenex cream, which treats the wound through rapid tissue regeneration; REJURAN HEALER, an intra dermal injection to enhance elasticity, turgidity, and tonicity of skin; Rejuran i and Rejuran s intra dermal or cannula injections; REJURAN moisturizer for daily skin protection; REJURAN concentrate for sensitive and aged skin; REJURAN healing eye gel; REJURAN healing cream and mask; REJURAN sunscreen that protects skin from UV rays; and REJURAN recover soothing mask. It also provides D+CELL 350 TRA concentrated rejuvenation cream, intensive repair serum, activating facial toner, high potency eye lift, moisture balancer, mask, hair, cream, and hydro products; REJURAN tone-up booster; and CLEVIEL prime plus and contour plus with lidocaine medical devices, as well as CONJURAN medical devices. In addition, the company offers functional foods under the REJULINE, REJUSHINE, and REJULIGHT brands. The company was formerly known as Pharma Research Products Co., Ltd. and changed its name to PharmaResearch Co., Ltd. in April 2021. PharmaResearch Co., Ltd. was founded in 1993 and is headquartered in Seongnam, South Korea.
Q&A For PharmaResearch Co., Ltd. Stock
What is a current 214450.KQ stock price?
PharmaResearch Co., Ltd. 214450.KQ stock price today per share is 125100 KRW.
How to purchase PharmaResearch Co., Ltd. stock?
You can buy 214450.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PharmaResearch Co., Ltd.?
The stock symbol or ticker of PharmaResearch Co., Ltd. is 214450.KQ.
How many shares does PharmaResearch Co., Ltd. have in circulation?
The max supply of PharmaResearch Co., Ltd. shares is 9.47M.
What is PharmaResearch Co., Ltd. Price to Earnings Ratio (PE Ratio)?
PharmaResearch Co., Ltd. PE Ratio is now.
What was PharmaResearch Co., Ltd. earnings per share over the trailing 12 months (TTM)?
PharmaResearch Co., Ltd. EPS is 0 KRW over the trailing 12 months.
PharmaResearch Co., Ltd. 214450.KQ included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Kosdaq Manufacturing Index KQ12 | 2779.56 KRW 2.1 USD |
-1.27
|
210.65K KRW 159 USD | 2753.96 KRW 2.08 USD | 2788.98 KRW 2.11 USD | — - | 210.65K KRW 159 USD |
Kosdaq 100 Index KQ100 | 2012.77 KRW 1.52 USD |
-1.23
|
37.53K KRW 28 USD | 1997.54 KRW 1.51 USD | 2024.99 KRW 1.53 USD | — - | 37.53K KRW 28 USD |
Kosdaq Pharmaceuticals Index KQ26 | 9230.64 KRW 6.97 USD |
-0.48
|
22.23K KRW 17 USD | 9102.9 KRW 6.87 USD | 9268.21 KRW 7 USD | — - | 22.23K KRW 17 USD |
- {{ link.label }} {{link}}